Anti-tumor combinations comprising proteins and chemotherapeutics
EP1379267A1
The use of the protein uk114 for the treatment and the prevention of chronic active hepatitis
PL367764A1
Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock
AU5825701A
A novel tumor-related antigen
PL353003A1
The use of the protein uk 114 for inhibiting organ transplant rejection
AU4293600A
Recombinant protein uk114 and its use in therapy and diagnostics
EP1090107A1
Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production
AU2624499A
Oral compositions at low dosage of cytotoxic proteins
WO9842366A1
The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
CZ338499A3
Use of proteins extractable from levers of mammals
AU4774797A
Use of proteins as agents against autoimmune diseases
BR9711789A
Use of proteins as antiretroviral agents
AU2894597A
A cytofluorometric method for the determination in serum of antibodies against tumoral antigens
US6107474A
Nucleotide sequence encoding a 14 kDa protein from goat liver
ITMI961921A1
Using proteins from mammalian liver as agents against auto-immune disease - by preparing medicaments useful to prevent and treat atherosclerosis following transplants, arthritis, multiple sclerosis or diabetes
ITMI961920A1
Using proteins from mammalian liver as agents against auto-immune disease - by preparing medicaments useful to prevent and treat atherosclerosis following transplants, arthritis, multiple sclerosis or diabetes
ITMI961922A1
Using proteins from mammalian liver as agents against auto-immune disease - by preparing medicaments useful to prevent and treat atherosclerosis following transplants, arthritis, multiple sclerosis or diabetes
ITMI961919A1
Using proteins from mammalian liver as agents against auto-immune disease - by preparing medicaments useful to prevent and treat atherosclerosis following transplants, arthritis, multiple sclerosis or diabetes
WO9641641A1
Pharmaceutical compositions with analgesic activity
NZ295171A
Antibodies against allogenic and xenogenic proteins and their use in diagnosis
